**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no
implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information
is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
AGE - European Older People's Platform
Address:
Rue Froissart 111
Bruxelles, Intl 1040
Belgium
Phone: +32-.2.-280.14.70
Fax: +32-.2.-280.15.22
800 Number: --
TDD: --
Email Address: info@age-platform.org
AGE, the European Older People's Platform, is a non-profit network of organizations and individuals that aims to promote good policy and practice on aging in the interests of older people in the European Union. AGE represents all areas of aging policy and older people's interests, but draws its legitimacy from the fact that older people are directly represented in AGE. The organization voices and defends the interests of older and retired people in the European Union and raises awareness of the issues that truly concern them. AGE saw the light in January 2001after a two-year consultation process between the different existing European networks of older people's associations. One of its main activities is to monitor the transposition and the implementation of the anti discrimination directives in the 15 EU member states. The main underlying principle of AGE's work is the recognition of older and retired people as a resource.
Website: http://www.age-platform.org/EN/
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted
by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to
the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes
without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on
an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source
(NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed
versions are strictly prohibited.